Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E A Luchinin"'
Autor:
M. V. Zhuravleva, M. Yu. Frolov, E. A. Luchinin, K. A. Kokushkin, E. D. Laryushkina, T. R. Kameneva, E. V. Kuznetsova
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 42-52 (2023)
Relevance. Cardio-vascular diseases (CVD) are the one of the main reasons of mortality and disability. Hypercholesterinemia is a factor of CVD progression, and thus it should be corrected. Combination of statin + ezetemib is an effective option of a
Externí odkaz:
https://doaj.org/article/c063a5e65d414409b2c30d1d25b16032
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 15-25 (2023)
Multiple myeloma (MM) accounts for 1 % of all cancers and about 10 % of all hemoblastoses. The use of innovative technologies with the inclusion of targeted drugs leads to a significant improvement in the quality of pharmacotherapy and the achievemen
Externí odkaz:
https://doaj.org/article/84887573e1e043e4b7fa05d5a39873dd
Autor:
M. V. Zhuravleva, G. V. Kukushkin, E. V. Luchinina, T. V. Shelekhova, T. R. Kameneva, E. V. Kuznetsova, E. A. Luchinin
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 41-52 (2022)
Relevance. Ademetionine is a hepatoprotective drug, is included in the draft Russian clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) and in the clinical guidelines for treating intrahepatic cholestasis
Externí odkaz:
https://doaj.org/article/4764411672e14f94a71c914d6b7d389e
Publikováno v:
Problems of Social Hygiene, Public Health and History of Medicine. 30:1004-1009
The article is a comparative analysis of the quality of life indicators of patients with rheumatoid arthritis with similar indicators in the Moscow population. We conducted a survey of patients in the register of rheumatoid patients in Moscow using t
Publikováno v:
Onkourologiâ, Vol 17, Iss 2, Pp 112-127 (2021)
Objective: to determine the economic and clinical consequences of using atezolizumab in metastatic urothelial cancer compared with pembrolizumab and nivolumab.Materials and methods. An assessment of the effectiveness and safety of medicines for uroth
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29
Interest in chloroquine, and its analog with a more favorable safety profile - hydroxychloroquine, in 2020 is certainly associated with the outbreak of a new coronavirus infection, SARS-CoV-2. The high pathogenicity and lack of specific immunity in t
Publikováno v:
Problems of Social Hygiene Public Health and History of Medicine. 28
The article presents a review of the historical facts related to the discovery and introduction of chloroquine and hydroxychloroquine. The history of studying aminoquinoline preparations is associated with the discovery of the antimalarial action of